Blog

Weizmann Institute: Surprising Neuro-Hypophysis Discovery

November 7, 2011 | No comments

In a study published recently in Developmental Cell, a team of scientists led by Dr. Gil Levkowitz of the Weizmann Institute has revealed the exact structure of one crucial brain area in which biochemical commands are passed from the brain cells to the bloodstream and from there to the body....

CollPlant Gel in Diabetic Ulcer Trial

November 7, 2011 | No comments

CollPlant has launched a clinical study for a gel to accelerate healing diabetic ulcers based on its recombinant human collagen grown in tobacco plants. CollPlant expects to sell the product in 2013. The market for the gel is estimated at $250 million a year. Because collagen is a structural protein...

Neetour: Respiratory Monitor Trial

November 7, 2011 | No comments

Necessity is the mother of invention: When Dr. Ofer Hornick, looking for a way to monitor the breathing of patients in his anxiety clinic, realized that the kind of device he needed didn’t exist, he began a process that led to the invention of a technology that monitors in real-time...

BiondVax Plans Phase II Flu Vaccine

November 7, 2011 | No comments

BiondVax Pharmaceuticals has announced plans to start a second Phase II trial for the development of a product that is intended to enhance the effectiveness of existing flu vaccines. That product aims to be the forerunner of the company`s ultimate goal – the development of a universal flu vaccine. The...

D-Pharm Phase III Stroke Report in Feb.

November 7, 2011 | No comments

The next crucial milestone is near for the more than 15-year development of a major new ethical Israeli drug. D-Pharm Ltd., (TASE: DPRM) announced that it will be able to determine in February if initial results for its Phase III stroke drug trial indicate enough evidence of a beneficial effect...